Reports
Reports
Sale
The global stem cell assay market size was valued at USD 6.4 billion in 2023, with Europe holding a significant market share. The market is driven by the rising technological innovations in the field of stem cell assays. It is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Stem cell assays are laboratory tests that are used to evaluate the behavior or function of stem cells. In Europe, they are widely utilized in clinical and research settings to obtain data on stem cell differentiation, viability, and proliferation, among others. These assays are increasingly employed in cancer research and regenerative medicine to find potential treatments for various diseases. The rising prevalence of chronic conditions including diabetes, cardiovascular diseases, and neurodegenerative disorders is expected to drive the Europe stem cell assay market growth in the coming years.
The market is significantly impacted by the rising aging population. On January 1, 2023, it was estimated that more than one-fifth of the population of the European Union was aged 65 years and above, with the median age reaching 44.5 yea rs. This growing size of the aging population in Europe reflects the need for novel therapeutic solutions, including those developed through stem cell research, which is likely to drive the market demand in the forecast period.
The rising integration of advanced and automated cell counting methods to assess stem cell viability is leading to a reduction in analyst-dependent variability and the analytical time in research labs and manufacturing facilities . This is anticipated to propel the Europe stem cell assay market demand. Additionally, these rising technological advancements in the field of stem cell assays such as high-throughput screening technologies are likely to boost efficiency and improve the accuracy of stem cell research and testing, thereby supporting market growth.
In Europe, the rising emphasis for stem cell research coupled with the presence of an established research infrastructure in the region is accelerating market growth. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom. Such stem cell-based research activities are likely to augment the demand for various types of stem cell assays to understand stem cell biology and consequently develop stem cell therapies, ultimately elevating the market value.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
Type | Viability/Cytotoxicity Assays, Isolation & Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
Product & Service | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
Treatment | Allogeneic Stem Cell Therapy, Autologous St |
Application | Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research, Others |
End User | Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others |
Countries | United Kingdom, Germany, France, Italy, Others |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Cell Type |
|
Breakup by Type |
|
Breakup by Product & Service |
|
Breakup by Treatment |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Stem Cell Assay Market Overview
3.1 Europe Stem Cell Assay Market Historical Value (2017-2023)
3.2 Europe Stem Cell Assay Market Forecast Value (2024-2032)
4 Europe Stem Cell Assay Market Landscape*
4.1 Europe Stem Cell Assay: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Stem Cell Assay: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 Europe Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Stem Cell Assay Market Segmentation (2017-2032)
6.1 Europe Stem Cell Assay Market (2017-2032) by Cell Type
6.1.1 Market Overview
6.1.2 Adult Stem Cells
6.1.3 Human Embryonic Stem Cells
6.1.4 Pluripotent
6.2 Europe Stem Cell Assay Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Viability /Cytotoxicity Assays
6.2.3 Isolation & Purification Assays
6.2.4 Cell Identification Assays
6.2.5 Proliferation Assays
6.2.6 Differentiation Assays
6.2.7 Function Assays
6.2.8 Apoptosis Assays
6.2.9 Others
6.3 Europe Stem Cell Assay Market (2017-2032) by Product & Service
6.3.1 Market Overview
6.3.2 Flow Cytometers
6.3.3 Cell Imaging & Analysis Systems
6.3.4 Microelectrode Arrays
6.3.5 Automated Cell Counters
6.3.6 Kits
6.4 Europe Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 Europe Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine &Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 Europe Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 Europe Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United Kingdom
6.7.3 Germany
6.7.4 France
6.7.5 Italy
6.7.6 Others
7 United Kingdom of Stem Cell Assay Market (2017-2032)
7.1 United Kingdom Stem Cell Assay Market (2017-2032) by Cell Type
7.1.1 Market Overview
7.1.2 Adult Stem Cells
7.1.3 Human Embryonic Stem Cells
7.1.4 Pluripotent
7.2 United Kingdom Stem Cell Assay Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Viability /Cytotoxicity Assays
7.2.3 Isolation & Purification Assays
7.2.4 Cell Identification Assays
7.2.5 Proliferation Assays
7.2.6 Differentiation Assays
7.2.7 Function Assays
7.2.8 Apoptosis Assays
7.2.9 Others
7.3 United Kingdom Stem Cell Assay Market (2017-2032) by Product & Service
7.3.1 Market Overview
7.3.2 Flow Cytometers
7.3.3 Cell Imaging & Analysis Systems
7.3.4 Microelectrode Arrays
7.3.5 Automated Cell Counters
7.3.6 Kits
7.4 United Kingdom Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 United Kingdom America Stem Cell Assay Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Biopharmaceutical & Biotechnology Companies
7.5.3 Academic & Research Institutes
7.5.4 Others
7.6 United Kingdom Stem Cell Assay Market (2017-2032) by Application
7.6.1 Market Overview
7.6.2 Regenerative Medicine &Therapy Development
7.6.3 Drug Discovery & Development
7.6.4 Clinical Research
7.6.5 Others
8 Germany Stem Cell Assay Market (2017-2032)
8.1 Germany Stem Cell Assay Market (2017-2032) by Cell Type
8.1.1 Market Overview
8.1.2 Adult Stem Cells
8.1.3 Human Embryonic Stem Cells
8.1.4 Pluripotent
8.2 Germany Stem Cell Assay Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Viability /Cytotoxicity Assays
8.2.3 Isolation & Purification Assays
8.2.4 Cell Identification Assays
8.2.5 Proliferation Assays
8.2.6 Differentiation Assays
8.2.7 Function Assays
8.2.8 Apoptosis Assays
8.2.9 Others
8.3 Germany Stem Cell Assay Market (2017-2032) by Product & Service
8.3.1 Market Overview
8.3.2 Flow Cytometers
8.3.3 Cell Imaging & Analysis Systems
8.3.4 Microelectrode Arrays
8.3.5 Automated Cell Counters
8.3.6 Kits
8.4 Germany Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Germany Stem Cell Assay Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Biopharmaceutical & Biotechnology Companies
8.5.3 Academic & Research Institutes
8.5.4 Others
8.6 Germany Stem Cell Assay Market (2017-2032) by Application
8.6.1 Market Overview
8.6.2 Regenerative Medicine &Therapy Development
8.6.3 Drug Discovery & Development
8.6.4 Clinical Research
9 France Stem Cell Assay Market (2017-2032)
9.1 France Stem Cell Assay Market (2017-2032) by Cell Type
9.1.1 Market Overview
9.1.2 Adult Stem Cells
9.1.3 Human Embryonic Stem Cells
9.1.4 Pluripotent
9.2 France Stem Cell Assay Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Viability /Cytotoxicity Assays
9.2.3 Isolation & Purification Assays
9.2.4 Cell Identification Assays
9.2.5 Proliferation Assays
9.2.6 Differentiation Assays
9.2.7 Function Assays
9.2.8 Apoptosis Assays
9.2.9 Others
9.3 France Stem Cell Assay Market (2017-2032) by Product & Service
9.3.1 Market Overview
9.3.2 Flow Cytometers
9.3.3 Cell Imaging & Analysis Systems
9.3.4 Microelectrode Arrays
9.3.5 Automated Cell Counters
9.3.6 Kits
9.4 France Stem Cell Assay Market (2017-2032) by Treatment
9.4.1 Market Overview
9.4.2 Allogeneic Stem Cell Therapy
9.4.3 Autologic Stem Cell Therapy
9.4.4 Syngeneic Stem Cell Therapy
9.5 France Stem Cell Assay Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Biopharmaceutical & Biotechnology Companies
9.5.3 Academic & Research Institutes
9.5.4 Others
9.6 France Stem Cell Assay Market (2017-2032) by Application
9.6.1 Market Overview
9.6.2 Regenerative Medicine &Therapy Development
9.6.3 Drug Discovery & Development
9.6.4 Clinical Research
9.6.5 Others
10 Italy Stem Cell Assay Market (2017-2032)
10.1 Italy Stem Cell Assay Market (2017-2032) by Cell Type
10.1.1 Market Overview
10.1.2 Adult Stem Cells
10.1.3 Human Embryonic Stem Cells
10.1.4 Pluripotent
10.2 Italy Stem Cell Assay Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 Viability /Cytotoxicity Assays
10.2.3 Isolation & Purification Assays
10.2.4 Cell Identification Assays
10.2.5 Proliferation Assays
10.2.6 Differentiation Assays
10.2.7 Function Assays
10.2.8 Apoptosis Assays
10.2.9 Others
10.3 Italy Stem Cell Assay Market (2017-2032) by Product & Service
10.3.1 Market Overview
10.3.2 Flow Cytometers
10.3.3 Cell Imaging & Analysis Systems
10.3.4 Microelectrode Arrays
10.3.5 Automated Cell Counters
10.3.6 Kits
10.4 Italy Stem Cell Assay Market (2017-2032) by Treatment
10.4.1 Market Overview
10.4.2 Allogeneic Stem Cell Therapy
10.4.3 Autologic Stem Cell Therapy
10.4.4 Syngeneic Stem Cell Therapy
10.5 Italy Stem Cell Assay Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Biopharmaceutical & Biotechnology Companies
10.5.3 Academic & Research Institutes
10.5.4 Others
10.6 Italy Stem Cell Assay Market (2017-2032) by Application
10.6.1 Market Overview
10.6.2 Regenerative Medicine &Therapy Development
10.6.3 Drug Discovery & Development
10.6.4 Clinical Research
10.6.5 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Thermo Fisher Scientific
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 PerkinElmer
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Stemcell Technologies
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Merck
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Bio-Rad Laboratories
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Agilent Technologies
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Promega
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Bio-Techne
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Cell Biolabs
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Europe Stem Cell Assay Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The Europe stem cell assay market is expected to be driven by the rising demand for the global stem cell assay market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
The rising application of stem cell assays in cancer research and regenerative medicine to find potential treatments for various chronic conditions is fuelling the demand for the market.
One of the significant trends in the market is the increased stem cell-based research activities which are likely to augment the demand for various types of stem cell assays. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom.
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
Based on the product and services, the market is segmented into flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
Major applications include regenerative medicine and therapy development, drug discovery and development, as well as clinical research, among others.
End users of the market are biopharmaceutical and biotechnology companies, along with academic and research institutes, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.